StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Amneal Pharmaceuticals's cash was $127.64M at Jun 30, 2026. For fiscal 2025 it was $282.03M, up 138.2% from the year before. Over ten years it grew 15.8% a year on average. The highest annual figure on record is $347.12M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$282.03M+138.2%
FY2024Dec 31, 2024$118.42M+29.4%
FY2023Dec 31, 2023$91.54M+159.9%
FY2022Dec 31, 2022$35.23M-86.3%
FY2021Dec 31, 2021$256.74M-26.0%
FY2020Dec 31, 2020$347.12M+127.1%
FY2019Dec 31, 2019$152.82M-30.1%
FY2018Dec 31, 2018$218.78M+180.8%
FY2017Dec 31, 2017$77.92M+107.5%
FY2016Dec 31, 2016$37.55M-42.3%
FY2015Dec 31, 2015$65.11M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$127.64M+78.4%
Q1 FY2026Mar 31, 2026$197.66M+234.0%
Q4 FY2025Dec 31, 2025$282.03M+138.2%
Q3 FY2025Sep 30, 2025$201.25M+171.9%
Q2 FY2025Jun 30, 2025$71.54M+63.5%
Q1 FY2025Mar 31, 2025$59.19M+27.2%
Q4 FY2024Dec 31, 2024$118.42M+29.4%
Q3 FY2024Sep 30, 2024$74.01M-14.9%
Q2 FY2024Jun 30, 2024$43.77M-59.9%
Q1 FY2024Mar 31, 2024$46.52M-67.8%
Q4 FY2023Dec 31, 2023$91.54M+159.9%
Q3 FY2023Sep 30, 2023$86.93M-0.5%
Q2 FY2023Jun 30, 2023$109.28M+18.8%
Q1 FY2023Mar 31, 2023$144.67M-31.3%
Q4 FY2022Dec 31, 2022$35.23M-86.3%
Q3 FY2022Sep 30, 2022$87.34M-71.1%
Q2 FY2022Jun 30, 2022$91.98M-67.0%
Q1 FY2022Mar 31, 2022$210.48M-53.4%
Q4 FY2021Dec 31, 2021$256.74M-26.0%
Q3 FY2021Sep 30, 2021$302.66M+7.6%
Q2 FY2021Jun 30, 2021$278.31M+4.6%
Q1 FY2021Mar 31, 2021$452.10M+11.6%
Q4 FY2020Dec 31, 2020$347.12M+127.1%
Q3 FY2020Sep 30, 2020$281.28M+32.2%
Q2 FY2020Jun 30, 2020$266.14M+384.8%
Q1 FY2020Mar 31, 2020$405.24M+533.7%
Q4 FY2019Dec 31, 2019$152.82M-30.1%
Q3 FY2019Sep 30, 2019$212.74M+28.8%
Q2 FY2019Jun 30, 2019$54.89M-10.8%
Q1 FY2019Mar 31, 2019$63.95M+32.6%
Q4 FY2018Dec 31, 2018$218.78M+180.8%
Q3 FY2018Sep 30, 2018$165.19M+753.8%
Q2 FY2018Jun 30, 2018$61.52M+27.6%
Q1 FY2018Mar 31, 2018$48.22M+28.4%
Q4 FY2017Dec 31, 2017$77.92M+19.7%
Q3 FY2017Sep 30, 2017$19.35M–
Q2 FY2017Jun 30, 2017$48.22M–
Q4 FY2016Dec 31, 2016$37.55M–
Q4 FY2015Dec 31, 2015$65.11M–

More Amneal Pharmaceuticals figures

See a number that looks wrong?